IL17A and Alzheimer disease: The KEGG and GO enrichment analysis results showed that the active components of Osteoking might exert such molecular functions as endopeptidase activity, protein kinase activity and kinase binding through such biological processes as positive regulation of cell motility, gland development, positive regulation of phosphorylation in membrane raft, extracellular matrix and vesicle lumen and then regulate pathways in cancer, Alzheimer disease, microRNAs in cancer, IL-17 signalling pathway and other pathways.